Human Nucleus Pulposis Can Respond to a Pro-inflammatory Stimulus

Spine

Volumn 28, Issue 24, 2003, Pages 2685-2693

  Burke, John G ^a,c   Watson, R W G ^a   Conhyea, D ^b   McCormack, D ^a   Dowling, F E ^b   Walsh, M G ^a   Fitzpatrick, J M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c NONE   (United Kingdom)

Author keywords

Cytokine; Intervertebral disc; Lipopolysaccharide; Tumor necrosis factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK DISEASE; MALE; NUCLEUS PULPOSUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE CULTURE;

ADOLESCENT; ADULT; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CULTURE TECHNIQUES; DINOPROSTONE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; INTERVERTEBRAL DISK; LIPOPOLYSACCHARIDES; MALE; SPINAL DISEASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0346120078     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000103341.45133.F3     Document Type: Article

References (49)

1. Emery P, Buch M. Treating rheumatoid arthritis with tumour necrosis factor αblockade. Br Med J. 2002;324:312-313.
2. Bell S, Kamm MA. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet. 2000;355:858-860.
3. Igarashi T, Kikuchi S, Shubayev V, et al. 2000 Volvo Award Winner in basic science studies: exogenous tumour necrosis factor alpha mimics nucleus pulposus induced neuropathology. Molecular, histologic and behavioural comparisons in rats. Spine. 2000;25:2975-2980.
4. Olmarker K, Larsson K. Tumour necrosis factor alpha and nucleuspulposus-induced nerve root injury. Spine. 1998;23:2538-2544.
5. Takahashi H, Suguro T, Okazima Y, et al. Inflammatory cytokines in the herniated disc of the lumbar spine. Spine. 1996;21:218-224.
6. Yabuki S, Onda A, Kikuchi S, et al. Prevention of compartment syndrome in dorsal root ganglia caused by exposure to nucleus pulposus. Spine. 2001;26:870-875.
7. Rand N, Reichert F, Floman Y, et al. Murine NP-derived cells secrete interleukins-1-b, -6, and -10, granulocyte-macrophage colony-stimulating factor in cell culture. Spine. 1997;22:2598-2602.
8. th Annual Meeting, 2001:3-4.
9. Burke JG, Watson RWG, McCormack D, et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002;84:196-201.
10. Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1996;21:271-277.
11. Kang JD, Georgescu HI, McIntyre-Larkin L, et al. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine. 1995;20:2373-2378.
12. Burke JG, Watson RWG, McCormack D, et al. Spontaneous disc herniation resorption may be mediated by chemokines. Spine. 2002;27:1402-1407.
13. Haro H, Shinomiya K, Komori H, et al. Upregulated expression of chemokines in herniated NP resorption. Spine. 1996;21:1647-1652.
14. Kikuchi T, Nakamura T, Ikeda T, et al. Monocyte chemoattractant protein-1 in the intervertebral disc: a histologic experimental model. Spine. 1998;23:1091-1099.
15. Nagano S, Matsunaga S, Takae R, et al. Immunolocalisation of transforming growth factor-betas and their receptors in the intervertebral disc of senescence-accelerated mouse. Int J Oncol. 2000;17:461-466.
16. Nishida K, Kang JD, Gilbertson LG, et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine. 1999;24:2419-2425.
17. Specchia N, Pagnotta A, Toesca A, et al. Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine. Eur Spine J. 2002;11:145-151.
18. Nagano T, Yonenobu K, Miyamoto S, et al. Distribution of the basic fibroblast growth factor and its receptor gene expression in normal and degenerated rat intervertebral discs. Spine. 1995;20:1972-1978.
19. Tolonen J, Gronblad M, Virri J, et al. Basic fibroblast growth factor immunoreactivity in blood vessels and cells of disc herniations. Spine. 1995;20:271-276.
20. Saal JS, Franson RC, Dobrow R, et al. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine. 1990;15:674-678.
21. Nygaard OP, Mellgren SI, Osterud B. The Inflammatory properties of contained and noncontained lumbar disc herniation. Spine. 1997;22:2484-2488.
22. O'Donnell JL, O'Donnell AL. Prostaglandin E2 content in herniated lumbar disc disease. Spine. 1996;21:1653-1656.
23. Kang JD, Stefanovic-Racic M, McIntyre LA, et al. Toward a biochemical understanding of human intervertebral disc degeneration and herniation: contributions of nitric oxide, interleukins, prostaglandin E2 and matrix metalloproteinases. Spine. 1997;22:1065-1073.
24. Doita M, Kanatani T, Harada T, et al. Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine. 1996;21:235-241.
25. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
26. Bauer J, Ganter U, Geiger T, et al. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood. 1988;72:1134-1140.
27. Beutler B, Han J, Kruys V, et al. Coordinate regulation of TNF biosynthesis at the levels of transcription and translation: patterns of TNF expression in vivo. In: Beutler B, ed. Tumour Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York: Raven Press, 1992:561-574.
28. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation: regulation of IL-8 expression by human articular chondrocytes. J Immunol. 1992;148:466-473.
29. Sidhu RS, Bollon AP. Tumour necrosis factor activities and cancer therapy: a perspective. Pharmacol Ther. 1993;57:79-128.
30. Olmarker K, Rydevik B. Selective inhibition of tumour necrosis factor alpha prevents NP induced thrombus formation, intraneural edema and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine. 2001;26:863-869.
31. Stirling AJ, Worthington T, Rafiq M, et al. Association between sciatica and Propionibacterium acnes. Lancet. 2001;357:2024-2025.
32. Wehling P, Cleveland SJ, Heininger K, et al. Neurophysiologic changes in lumbar nerve root inflammation in the rat after treatment with cytokine inhibitors: evidence for a role of interleukin-1. Spine. 1996;21:931-935.
33. Strieter R, Polverini PJ, Kunkel SL. The functional role of the ELR motif in CXC chemokine mediated angiogenesis. J Biol Chem. 1995;270:27348-27357.
34. Sweitzer SM, DeLeo JA. Prevention of compartment syndrome in dorsal root ganglia caused by exposure to nucleus pulposus: point of view. Spine. 2001;26:874-875.
35. Rannou F, Corvol MT, Hudry C, et al. Sensitivity of annulus fibrosus cells to interleukin 1 beta: comparison with articular chondrocytes. Spine. 2000;25:17-23.
36. Willburger RE, Wittenberg RH. Prostaglandin release from lumbar disc and facet joint tissue. Spine. 1994;19:2068-2070.
37. Haro H, Komori K, Okawa A, et al. Sequential dynamics of monocyte chemotactic protein-1 expression in herniated NP resorption. J Orthop Res. 1997;15:734-741.
38. Konttinen YT, Kemppinen P, Li P, et al. Transforming and epidermal growth factors in degenerated intervertebral discs. J Bone Joint Surg Br. 1999;81:1058-1063.
39. Moon SH, Gilbertson LG, Nishida K, et al. Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine. 2000;25:2573-2579.
40. Thompson JP, Oegema TR, Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine. 1991;16:253-260.
41. Kawaguchi S, Yamashita T, Yokogushi K, et al. Immunophenotypic analysis of the inflammatory infiltrates in herniated intervertebral discs. Spine. 2001;26:1209-1214.
42. Tanaka A. A histopathological study on the intervertebral discs of idiopathic and paralytic scoliosis: abnormalities in transition from the notochordal nucleus to the fibrocartilaginous nucleus. Nippon Seikeigaka Gakkai Zasshi. 1986;60:1227-1238.
43. Gronblad M, Virri J, Tolonen J, et al. A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine. 1994;19:2744-2751.
44. Ikeda T, Nakamura T, Kikuchi T, et al. Pathomechanism of spontaneous regression of the herniated lumbar disc: histologic and immunohistochemical study. J Spinal Disord. 1996;9:136-140.
45. Ito T, Yamada M, Ikuta F, et al. Histologic evidence of absorption of sequestration-type herniated disc. Spine. 1996;21:230-234.
46. Yasuma T, Arai K, Yamauchi Y. The histology of lumbar intervertebral disc herniation. Spine. 1993;18:1761-1765.
47. Roberts S, Menage J, Evans EH, et al. Inflammation of the intervertebral disc: an uncommon finding in discs associated with discogenic back pain. J Bone Joint Surg Br. 2000;82(suppl 2):98.
48. Bibby SRS, Fairbank JCT, Urban JPG. Cell viability in scoliotic discs in relation to load. J Bone Joint Surg Br. 2002;84(suppl 2):139.
49. th Annual Meeting, 2000:89-92.